img

Global Iron Deficiency Injectable Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Iron Deficiency Injectable Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Iron deficiency injectables are the drugs which are prescribed for treating iron deficiency and delivered by intravenous (IV) infusion in the body. These IV drugs offer numerous benefits over oral medications by guaranteeing faster absorption of the infused supplements. Iron-deficiency anaemia is a disorder in which the blood does not have enough healthy red blood cells due to the deficiency of iron. For treating these patiets, these injectables are used. It is used only for the treatment of patients who cannot be treated appropriately with oral iron supplements.
Iron Deficiency Injectable report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Iron Deficiency Injectable market is projected to reach US$ 5073.7 million in 2029, increasing from US$ 2923 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2029. Demand from Chronic Kidney Disease and Inflammatory Bowel Disease are the major drivers for the industry.
Currently, increasing geriatric population, increasing prevalence of chronic diseases such as cancer, chronic kidney disease, and rising number of patients undergoing dialysis are driving the iron deficiency injectables market. High prevalence of iron deficiency anemia due to polycystic ovary syndrome (PCOS) and rising incidence of hemodilution in pregnant women are also increasing the demand for iron deficiency injections.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Iron Deficiency Injectable market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie Inc
Covis Pharma GmbH
DAIICHI SANKYO COMPANY, LIMITED
Fresenius Kabi AG
Vifor Pharma Management Ltd
PHARMACOSMOS A/S
Shield Therapeutics plc
American Regent, Inc
Rockwell Medical, Inc
Apotex Inc
Bayer AG
Akebia Therapeutics, Inc
GSK plc
Novartis AG
Aetna Inc
Pfizer Inc
Systacare Remedies
BSA Pharma Inc
Segment by Type
Iron Dextran
Iron Sucrose
Ferric Carboxymaltose

Segment by Application


Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Iron Deficiency Injectable market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Iron Deficiency Injectable, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Iron Deficiency Injectable industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Iron Deficiency Injectable in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Iron Deficiency Injectable introduction, etc. Iron Deficiency Injectable Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Iron Deficiency Injectable market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Iron Deficiency Injectable Market Overview
1.1 Iron Deficiency Injectable Product Overview
1.2 Iron Deficiency Injectable Market Segment by Type
1.2.1 Iron Dextran
1.2.2 Iron Sucrose
1.2.3 Ferric Carboxymaltose
1.3 Global Iron Deficiency Injectable Market Size by Type
1.3.1 Global Iron Deficiency Injectable Market Size Overview by Type (2018-2029)
1.3.2 Global Iron Deficiency Injectable Historic Market Size Review by Type (2018-2024)
1.3.3 Global Iron Deficiency Injectable Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Iron Deficiency Injectable Sales Breakdown by Type (2018-2024)
1.4.2 Europe Iron Deficiency Injectable Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Iron Deficiency Injectable Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Iron Deficiency Injectable Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Iron Deficiency Injectable Sales Breakdown by Type (2018-2024)
2 Global Iron Deficiency Injectable Market Competition by Company
2.1 Global Top Players by Iron Deficiency Injectable Sales (2018-2024)
2.2 Global Top Players by Iron Deficiency Injectable Revenue (2018-2024)
2.3 Global Top Players by Iron Deficiency Injectable Price (2018-2024)
2.4 Global Top Manufacturers Iron Deficiency Injectable Manufacturing Base Distribution, Sales Area, Product Type
2.5 Iron Deficiency Injectable Market Competitive Situation and Trends
2.5.1 Iron Deficiency Injectable Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Iron Deficiency Injectable Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Iron Deficiency Injectable as of 2022)
2.7 Date of Key Manufacturers Enter into Iron Deficiency Injectable Market
2.8 Key Manufacturers Iron Deficiency Injectable Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Iron Deficiency Injectable Status and Outlook by Region
3.1 Global Iron Deficiency Injectable Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Iron Deficiency Injectable Historic Market Size by Region
3.2.1 Global Iron Deficiency Injectable Sales in Volume by Region (2018-2024)
3.2.2 Global Iron Deficiency Injectable Sales in Value by Region (2018-2024)
3.2.3 Global Iron Deficiency Injectable Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Iron Deficiency Injectable Forecasted Market Size by Region
3.3.1 Global Iron Deficiency Injectable Sales in Volume by Region (2024-2029)
3.3.2 Global Iron Deficiency Injectable Sales in Value by Region (2024-2029)
3.3.3 Global Iron Deficiency Injectable Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Iron Deficiency Injectable by Application
4.1 Iron Deficiency Injectable Market Segment by Application
4.1.1 Chronic Kidney Disease
4.1.2 Inflammatory Bowel Disease
4.1.3 Cancer
4.1.4 Other
4.2 Global Iron Deficiency Injectable Market Size by Application
4.2.1 Global Iron Deficiency Injectable Market Size Overview by Application (2018-2029)
4.2.2 Global Iron Deficiency Injectable Historic Market Size Review by Application (2018-2024)
4.2.3 Global Iron Deficiency Injectable Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Iron Deficiency Injectable Sales Breakdown by Application (2018-2024)
4.3.2 Europe Iron Deficiency Injectable Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Iron Deficiency Injectable Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Iron Deficiency Injectable Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Iron Deficiency Injectable Sales Breakdown by Application (2018-2024)
5 North America Iron Deficiency Injectable by Country
5.1 North America Iron Deficiency Injectable Historic Market Size by Country
5.1.1 North America Iron Deficiency Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Iron Deficiency Injectable Sales in Volume by Country (2018-2024)
5.1.3 North America Iron Deficiency Injectable Sales in Value by Country (2018-2024)
5.2 North America Iron Deficiency Injectable Forecasted Market Size by Country
5.2.1 North America Iron Deficiency Injectable Sales in Volume by Country (2024-2029)
5.2.2 North America Iron Deficiency Injectable Sales in Value by Country (2024-2029)
6 Europe Iron Deficiency Injectable by Country
6.1 Europe Iron Deficiency Injectable Historic Market Size by Country
6.1.1 Europe Iron Deficiency Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Iron Deficiency Injectable Sales in Volume by Country (2018-2024)
6.1.3 Europe Iron Deficiency Injectable Sales in Value by Country (2018-2024)
6.2 Europe Iron Deficiency Injectable Forecasted Market Size by Country
6.2.1 Europe Iron Deficiency Injectable Sales in Volume by Country (2024-2029)
6.2.2 Europe Iron Deficiency Injectable Sales in Value by Country (2024-2029)
7 Asia-Pacific Iron Deficiency Injectable by Region
7.1 Asia-Pacific Iron Deficiency Injectable Historic Market Size by Region
7.1.1 Asia-Pacific Iron Deficiency Injectable Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Iron Deficiency Injectable Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Iron Deficiency Injectable Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Iron Deficiency Injectable Forecasted Market Size by Region
7.2.1 Asia-Pacific Iron Deficiency Injectable Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Iron Deficiency Injectable Sales in Value by Region (2024-2029)
8 Latin America Iron Deficiency Injectable by Country
8.1 Latin America Iron Deficiency Injectable Historic Market Size by Country
8.1.1 Latin America Iron Deficiency Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Iron Deficiency Injectable Sales in Volume by Country (2018-2024)
8.1.3 Latin America Iron Deficiency Injectable Sales in Value by Country (2018-2024)
8.2 Latin America Iron Deficiency Injectable Forecasted Market Size by Country
8.2.1 Latin America Iron Deficiency Injectable Sales in Volume by Country (2024-2029)
8.2.2 Latin America Iron Deficiency Injectable Sales in Value by Country (2024-2029)
9 Middle East and Africa Iron Deficiency Injectable by Country
9.1 Middle East and Africa Iron Deficiency Injectable Historic Market Size by Country
9.1.1 Middle East and Africa Iron Deficiency Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Iron Deficiency Injectable Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Iron Deficiency Injectable Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Iron Deficiency Injectable Forecasted Market Size by Country
9.2.1 Middle East and Africa Iron Deficiency Injectable Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Iron Deficiency Injectable Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Inc Iron Deficiency Injectable Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Covis Pharma GmbH
10.2.1 Covis Pharma GmbH Company Information
10.2.2 Covis Pharma GmbH Introduction and Business Overview
10.2.3 Covis Pharma GmbH Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Covis Pharma GmbH Iron Deficiency Injectable Products Offered
10.2.5 Covis Pharma GmbH Recent Development
10.3 DAIICHI SANKYO COMPANY, LIMITED
10.3.1 DAIICHI SANKYO COMPANY, LIMITED Company Information
10.3.2 DAIICHI SANKYO COMPANY, LIMITED Introduction and Business Overview
10.3.3 DAIICHI SANKYO COMPANY, LIMITED Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.3.4 DAIICHI SANKYO COMPANY, LIMITED Iron Deficiency Injectable Products Offered
10.3.5 DAIICHI SANKYO COMPANY, LIMITED Recent Development
10.4 Fresenius Kabi AG
10.4.1 Fresenius Kabi AG Company Information
10.4.2 Fresenius Kabi AG Introduction and Business Overview
10.4.3 Fresenius Kabi AG Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Fresenius Kabi AG Iron Deficiency Injectable Products Offered
10.4.5 Fresenius Kabi AG Recent Development
10.5 Vifor Pharma Management Ltd
10.5.1 Vifor Pharma Management Ltd Company Information
10.5.2 Vifor Pharma Management Ltd Introduction and Business Overview
10.5.3 Vifor Pharma Management Ltd Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Vifor Pharma Management Ltd Iron Deficiency Injectable Products Offered
10.5.5 Vifor Pharma Management Ltd Recent Development
10.6 PHARMACOSMOS A/S
10.6.1 PHARMACOSMOS A/S Company Information
10.6.2 PHARMACOSMOS A/S Introduction and Business Overview
10.6.3 PHARMACOSMOS A/S Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.6.4 PHARMACOSMOS A/S Iron Deficiency Injectable Products Offered
10.6.5 PHARMACOSMOS A/S Recent Development
10.7 Shield Therapeutics plc
10.7.1 Shield Therapeutics plc Company Information
10.7.2 Shield Therapeutics plc Introduction and Business Overview
10.7.3 Shield Therapeutics plc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shield Therapeutics plc Iron Deficiency Injectable Products Offered
10.7.5 Shield Therapeutics plc Recent Development
10.8 American Regent, Inc
10.8.1 American Regent, Inc Company Information
10.8.2 American Regent, Inc Introduction and Business Overview
10.8.3 American Regent, Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.8.4 American Regent, Inc Iron Deficiency Injectable Products Offered
10.8.5 American Regent, Inc Recent Development
10.9 Rockwell Medical, Inc
10.9.1 Rockwell Medical, Inc Company Information
10.9.2 Rockwell Medical, Inc Introduction and Business Overview
10.9.3 Rockwell Medical, Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Rockwell Medical, Inc Iron Deficiency Injectable Products Offered
10.9.5 Rockwell Medical, Inc Recent Development
10.10 Apotex Inc
10.10.1 Apotex Inc Company Information
10.10.2 Apotex Inc Introduction and Business Overview
10.10.3 Apotex Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Apotex Inc Iron Deficiency Injectable Products Offered
10.10.5 Apotex Inc Recent Development
10.11 Bayer AG
10.11.1 Bayer AG Company Information
10.11.2 Bayer AG Introduction and Business Overview
10.11.3 Bayer AG Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bayer AG Iron Deficiency Injectable Products Offered
10.11.5 Bayer AG Recent Development
10.12 Akebia Therapeutics, Inc
10.12.1 Akebia Therapeutics, Inc Company Information
10.12.2 Akebia Therapeutics, Inc Introduction and Business Overview
10.12.3 Akebia Therapeutics, Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Akebia Therapeutics, Inc Iron Deficiency Injectable Products Offered
10.12.5 Akebia Therapeutics, Inc Recent Development
10.13 GSK plc
10.13.1 GSK plc Company Information
10.13.2 GSK plc Introduction and Business Overview
10.13.3 GSK plc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.13.4 GSK plc Iron Deficiency Injectable Products Offered
10.13.5 GSK plc Recent Development
10.14 Novartis AG
10.14.1 Novartis AG Company Information
10.14.2 Novartis AG Introduction and Business Overview
10.14.3 Novartis AG Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Novartis AG Iron Deficiency Injectable Products Offered
10.14.5 Novartis AG Recent Development
10.15 Aetna Inc
10.15.1 Aetna Inc Company Information
10.15.2 Aetna Inc Introduction and Business Overview
10.15.3 Aetna Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Aetna Inc Iron Deficiency Injectable Products Offered
10.15.5 Aetna Inc Recent Development
10.16 Pfizer Inc
10.16.1 Pfizer Inc Company Information
10.16.2 Pfizer Inc Introduction and Business Overview
10.16.3 Pfizer Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Pfizer Inc Iron Deficiency Injectable Products Offered
10.16.5 Pfizer Inc Recent Development
10.17 Systacare Remedies
10.17.1 Systacare Remedies Company Information
10.17.2 Systacare Remedies Introduction and Business Overview
10.17.3 Systacare Remedies Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Systacare Remedies Iron Deficiency Injectable Products Offered
10.17.5 Systacare Remedies Recent Development
10.18 BSA Pharma Inc
10.18.1 BSA Pharma Inc Company Information
10.18.2 BSA Pharma Inc Introduction and Business Overview
10.18.3 BSA Pharma Inc Iron Deficiency Injectable Sales, Revenue and Gross Margin (2018-2024)
10.18.4 BSA Pharma Inc Iron Deficiency Injectable Products Offered
10.18.5 BSA Pharma Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Iron Deficiency Injectable Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Iron Deficiency Injectable Industrial Chain Analysis
11.4 Iron Deficiency Injectable Market Dynamics
11.4.1 Iron Deficiency Injectable Industry Trends
11.4.2 Iron Deficiency Injectable Market Drivers
11.4.3 Iron Deficiency Injectable Market Challenges
11.4.4 Iron Deficiency Injectable Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Iron Deficiency Injectable Distributors
12.3 Iron Deficiency Injectable Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Iron Dextran
Table 2. Major Company of Iron Sucrose
Table 3. Major Company of Ferric Carboxymaltose
Table 4. Global Iron Deficiency Injectable Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Iron Deficiency Injectable Sales by Type (2018-2024) & (K Units)
Table 6. Global Iron Deficiency Injectable Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Iron Deficiency Injectable Sales by Type (2018-2024) & (US& Million)
Table 8. Global Iron Deficiency Injectable Market Share in Value by Type (2018-2024)
Table 9. Global Iron Deficiency Injectable Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Iron Deficiency Injectable Sales by Type (2024-2029) & (K Units)
Table 11. Global Iron Deficiency Injectable Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Iron Deficiency Injectable Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Iron Deficiency Injectable Sales Market Share in Value by Type (2024-2029)
Table 14. Global Iron Deficiency Injectable Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Iron Deficiency Injectable Sales by Type (2018-2024) & (K Units)
Table 16. North America Iron Deficiency Injectable Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Iron Deficiency Injectable Sales (K Units) by Type (2018-2024)
Table 18. Europe Iron Deficiency Injectable Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Iron Deficiency Injectable Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Iron Deficiency Injectable Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Iron Deficiency Injectable Sales (K Units) by Type (2018-2024)
Table 22. Latin America Iron Deficiency Injectable Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Iron Deficiency Injectable Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Iron Deficiency Injectable Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Iron Deficiency Injectable Sales by Company (2018-2024) & (K Units)
Table 26. Global Iron Deficiency Injectable Sales Share by Company (2018-2024)
Table 27. Global Iron Deficiency Injectable Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Iron Deficiency Injectable Revenue Share by Company (2018-2024)
Table 29. Global Market Iron Deficiency Injectable Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Iron Deficiency Injectable Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Iron Deficiency Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Iron Deficiency Injectable as of 2022)
Table 33. Date of Key Manufacturers Enter into Iron Deficiency Injectable Market
Table 34. Key Manufacturers Iron Deficiency Injectable Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Iron Deficiency Injectable Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Iron Deficiency Injectable Sales by Region (2018-2024) & (K Units)
Table 38. Global Iron Deficiency Injectable Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Iron Deficiency Injectable Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Iron Deficiency Injectable Sales Market Share in Value by Region (2018-2024)
Table 41. Global Iron Deficiency Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Iron Deficiency Injectable Sales by Region (2024-2029) & (K Units)
Table 43. Global Iron Deficiency Injectable Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Iron Deficiency Injectable Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Iron Deficiency Injectable Sales Market Share in Value by Region (2024-2029)
Table 46. Global Iron Deficiency Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Iron Deficiency Injectable Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Iron Deficiency Injectable Sales by Application (2018-2024) & (K Units)
Table 49. Global Iron Deficiency Injectable Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Iron Deficiency Injectable Sales Market Share in Value by Application (2018-2024)
Table 52. Global Iron Deficiency Injectable Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Iron Deficiency Injectable Sales by Application (2024-2029) & (K Units)
Table 54. Global Iron Deficiency Injectable Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Iron Deficiency Injectable Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Iron Deficiency Injectable Sales Market Share in Value by Application (2024-2029)
Table 57. Global Iron Deficiency Injectable Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Iron Deficiency Injectable Sales by Application (2018-2024) (K Units)
Table 59. North America Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Iron Deficiency Injectable Sales by Application (2018-2024) (K Units)
Table 61. Europe Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Iron Deficiency Injectable Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Iron Deficiency Injectable Sales by Application (2018-2024) (K Units)
Table 65. Latin America Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Iron Deficiency Injectable Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Iron Deficiency Injectable Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Iron Deficiency Injectable Sales by Country (2018-2024) & (K Units)
Table 69. North America Iron Deficiency Injectable Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Iron Deficiency Injectable Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Iron Deficiency Injectable Sales Market Share in Value by Country (2018-2024)
Table 72. North America Iron Deficiency Injectable Sales by Country (2024-2029) & (K Units)
Table 73. North America Iron Deficiency Injectable Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Iron Deficiency Injectable Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Iron Deficiency Injectable Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Iron Deficiency Injectable Sales by Country (2018-2024) & (K Units)
Table 77. Europe Iron Deficiency Injectable Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Iron Deficiency Injectable Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Iron Deficiency Injectable Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Iron Deficiency Injectable Sales by Country (2024-2029) & (K Units)
Table 81. Europe Iron Deficiency Injectable Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Iron Deficiency Injectable Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Iron Deficiency Injectable Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Iron Deficiency Injectable Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Iron Deficiency Injectable Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Iron Deficiency Injectable Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Iron Deficiency Injectable Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Iron Deficiency Injectable Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Iron Deficiency Injectable Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Iron Deficiency Injectable Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Iron Deficiency Injectable Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Iron Deficiency Injectable Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Iron Deficiency Injectable Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Iron Deficiency Injectable Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Iron Deficiency Injectable Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Iron Deficiency Injectable Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Iron Deficiency Injectable Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Iron Deficiency Injectable Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Iron Deficiency Injectable Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Value by Country (2024-2029)
Table 108. AbbVie Inc Company Information
Table 109. AbbVie Inc Introduction and Business Overview
Table 110. AbbVie Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. AbbVie Inc Iron Deficiency Injectable Product
Table 112. AbbVie Inc Recent Development
Table 113. Covis Pharma GmbH Company Information
Table 114. Covis Pharma GmbH Introduction and Business Overview
Table 115. Covis Pharma GmbH Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Covis Pharma GmbH Iron Deficiency Injectable Product
Table 117. Covis Pharma GmbH Recent Development
Table 118. DAIICHI SANKYO COMPANY, LIMITED Company Information
Table 119. DAIICHI SANKYO COMPANY, LIMITED Introduction and Business Overview
Table 120. DAIICHI SANKYO COMPANY, LIMITED Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. DAIICHI SANKYO COMPANY, LIMITED Iron Deficiency Injectable Product
Table 122. DAIICHI SANKYO COMPANY, LIMITED Recent Development
Table 123. Fresenius Kabi AG Company Information
Table 124. Fresenius Kabi AG Introduction and Business Overview
Table 125. Fresenius Kabi AG Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Fresenius Kabi AG Iron Deficiency Injectable Product
Table 127. Fresenius Kabi AG Recent Development
Table 128. Vifor Pharma Management Ltd Company Information
Table 129. Vifor Pharma Management Ltd Introduction and Business Overview
Table 130. Vifor Pharma Management Ltd Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Vifor Pharma Management Ltd Iron Deficiency Injectable Product
Table 132. Vifor Pharma Management Ltd Recent Development
Table 133. PHARMACOSMOS A/S Company Information
Table 134. PHARMACOSMOS A/S Introduction and Business Overview
Table 135. PHARMACOSMOS A/S Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. PHARMACOSMOS A/S Iron Deficiency Injectable Product
Table 137. PHARMACOSMOS A/S Recent Development
Table 138. Shield Therapeutics plc Company Information
Table 139. Shield Therapeutics plc Introduction and Business Overview
Table 140. Shield Therapeutics plc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Shield Therapeutics plc Iron Deficiency Injectable Product
Table 142. Shield Therapeutics plc Recent Development
Table 143. American Regent, Inc Company Information
Table 144. American Regent, Inc Introduction and Business Overview
Table 145. American Regent, Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. American Regent, Inc Iron Deficiency Injectable Product
Table 147. American Regent, Inc Recent Development
Table 148. Rockwell Medical, Inc Company Information
Table 149. Rockwell Medical, Inc Introduction and Business Overview
Table 150. Rockwell Medical, Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Rockwell Medical, Inc Iron Deficiency Injectable Product
Table 152. Rockwell Medical, Inc Recent Development
Table 153. Apotex Inc Company Information
Table 154. Apotex Inc Introduction and Business Overview
Table 155. Apotex Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Apotex Inc Iron Deficiency Injectable Product
Table 157. Apotex Inc Recent Development
Table 158. Bayer AG Company Information
Table 159. Bayer AG Introduction and Business Overview
Table 160. Bayer AG Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Bayer AG Iron Deficiency Injectable Product
Table 162. Bayer AG Recent Development
Table 163. Akebia Therapeutics, Inc Company Information
Table 164. Akebia Therapeutics, Inc Introduction and Business Overview
Table 165. Akebia Therapeutics, Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Akebia Therapeutics, Inc Iron Deficiency Injectable Product
Table 167. Akebia Therapeutics, Inc Recent Development
Table 168. GSK plc Company Information
Table 169. GSK plc Introduction and Business Overview
Table 170. GSK plc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. GSK plc Iron Deficiency Injectable Product
Table 172. GSK plc Recent Development
Table 173. Novartis AG Company Information
Table 174. Novartis AG Introduction and Business Overview
Table 175. Novartis AG Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Novartis AG Iron Deficiency Injectable Product
Table 177. Novartis AG Recent Development
Table 178. Aetna Inc Company Information
Table 179. Aetna Inc Introduction and Business Overview
Table 180. Aetna Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Aetna Inc Iron Deficiency Injectable Product
Table 182. Aetna Inc Recent Development
Table 183. Pfizer Inc Company Information
Table 184. Pfizer Inc Introduction and Business Overview
Table 185. Pfizer Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Pfizer Inc Iron Deficiency Injectable Product
Table 187. Pfizer Inc Recent Development
Table 188. Systacare Remedies Company Information
Table 189. Systacare Remedies Introduction and Business Overview
Table 190. Systacare Remedies Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Systacare Remedies Iron Deficiency Injectable Product
Table 192. Systacare Remedies Recent Development
Table 193. BSA Pharma Inc Company Information
Table 194. BSA Pharma Inc Introduction and Business Overview
Table 195. BSA Pharma Inc Iron Deficiency Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. BSA Pharma Inc Iron Deficiency Injectable Product
Table 197. BSA Pharma Inc Recent Development
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Iron Deficiency Injectable Market Trends
Table 201. Iron Deficiency Injectable Market Drivers
Table 202. Iron Deficiency Injectable Market Challenges
Table 203. Iron Deficiency Injectable Market Restraints
Table 204. Iron Deficiency Injectable Distributors List
Table 205. Iron Deficiency Injectable Downstream Customers
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Iron Deficiency Injectable Product Picture
Figure 2. Global Iron Deficiency Injectable Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Iron Deficiency Injectable Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Iron Deficiency Injectable Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Iron Dextran
Figure 6. Global Iron Dextran Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Iron Sucrose
Figure 8. Global Iron Sucrose Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Ferric Carboxymaltose
Figure 10. Global Ferric Carboxymaltose Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Iron Deficiency Injectable Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Iron Deficiency Injectable Sales Market Share by Type in 2022 & 2029
Figure 13. North America Iron Deficiency Injectable Sales Market Share in Volume by Type in 2022
Figure 14. North America Iron Deficiency Injectable Sales Market Share in Value by Type in 2022
Figure 15. Europe Iron Deficiency Injectable Sales Market Share in Volume by Type in 2022
Figure 16. Europe Iron Deficiency Injectable Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Value by Type in 2022
Figure 19. Latin America Iron Deficiency Injectable Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Iron Deficiency Injectable Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Iron Deficiency Injectable Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Iron Deficiency Injectable Revenue in 2022
Figure 25. Iron Deficiency Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Chronic Kidney Disease
Figure 27. Global Chronic Kidney Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Inflammatory Bowel Disease
Figure 29. Global Inflammatory Bowel Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Cancer
Figure 31. Global Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Iron Deficiency Injectable Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Iron Deficiency Injectable Sales Market Share by Application in 2022 & 2029
Figure 36. North America Iron Deficiency Injectable Sales Market Share in Volume by Application in 2022
Figure 37. North America Iron Deficiency Injectable Sales Market Share in Value by Application in 2022
Figure 38. Europe Iron Deficiency Injectable Sales Market Share in Volume by Application in 2022
Figure 39. Europe Iron Deficiency Injectable Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Iron Deficiency Injectable Sales Market Share in Value by Application in 2022
Figure 42. Latin America Iron Deficiency Injectable Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Iron Deficiency Injectable Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Iron Deficiency Injectable Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Iron Deficiency Injectable Manufacturing Cost Structure
Figure 47. Iron Deficiency Injectable Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries